Agency classClass IIOur severity:High FDA (Drugs)·D-0348-2026·Announced 2026-03-04

Vista Meibo Tears eye drops recalled over sterility assurance failure

Wizcure Pharmaa is recalling all lots of Vista Meibo Tears Propylene Glycol 0.6% eye drops because the products were not manufactured in conformance with current good manufacturing practices.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported: this is an FDA Class II recall of a sterile ophthalmic product whose sterility cannot be assured, with no injuries stated in the source.

Plain-English summary

Wizcure Pharmaa Private Limited is recalling Vista Meibo Tears Propylene Glycol 0.6% w/v Advanced Dry Eye Relief Lubricating Drops, 10 ml, NDC 77790-003-10, manufactured for and distributed by hi-health of Scottsdale, Arizona. About 11,520 cartons were distributed nationwide in the United States. The FDA has classified this recall as Class II.

The recall was initiated for lack of assurance of sterility: the products have not been manufactured in conformance with current good manufacturing practices.

All lots are affected.

Consumers can identify affected product by the NDC number above, and may contact Wizcure Pharmaa Private Limited for further information.

The recalled product

Product: VISTA MEIBO TEARS PROPYLENE GLYCOL 0.6% W/V ADVANCED DRY EYE RELIEF LUBRICATING DROPS 10 ML (PROPYLENE GLYCOL)
Brand: VISTA MEIBO TEARS PROPYLENE GLYCOL 0.6% W/V ADVANCED DRY EYE RELIEF LUBRICATING DROPS 10 ML
Manufacturer: Wizcure Pharmaa Private Limited
Category: Drug — Ophthalmic
Hazard: sterility-failure
gmp-violation
infection-risk
Affected units: 11,520

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

All lots

UPCs (1)

0091241453205

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 7 recalled by Wizcure Pharmaa Private Limited under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 7 products in this recall →

Same manufacturer · Wizcure Pharmaa Private Limited

See all →

High
Vista Tears lubricant eye drops recalled over sterility assurance failure
FDA (Drugs) · 2026-03-04
High
BioGlo fluorescein ophthalmic strips recalled over sterility assurance failure
FDA (Drugs) · 2026-03-04
Severe
Fluorescein Sodium Ophthalmic Strips Recalled Over Sterility Concerns
FDA (Drugs) · 2026-03-04
High
Vista Gonio Eye Lubricant Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-03-04
High
Vista Hypromelose Dry Eye Relief Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-03-04

Same hazard · sterility failure